26368-32-1 Usage
Uses
Used in Pharmaceutical Development:
2-amino-2-(1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid is used as a ligand for targeting specific receptors in the central nervous system for the development of pharmaceuticals. Its unique structure allows it to potentially interact with and modulate the activity of these receptors, which could be beneficial in the treatment of neurological conditions.
Used in Neurological Research:
2-amino-2-(1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid is used as a research tool for studying receptors in the brain. Its potential biological activities and interactions with specific receptors make it a valuable compound for understanding the mechanisms of action and potential therapeutic applications in the field of neuroscience.
Used in the Treatment of Neurological Conditions:
While more research is needed, 2-amino-2-(1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid may be used in the future as a therapeutic agent for the treatment of certain neurological conditions. Its potential as a ligand for specific receptors in the central nervous system suggests that it could play a role in modulating the activity of these receptors, potentially leading to improved outcomes for patients with neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 26368-32-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,3,6 and 8 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 26368-32:
(7*2)+(6*6)+(5*3)+(4*6)+(3*8)+(2*3)+(1*2)=121
121 % 10 = 1
So 26368-32-1 is a valid CAS Registry Number.
26368-32-1Relevant academic research and scientific papers
Thrombin inhibitors
-
Page column 27, (2010/02/06)
Novel five-membered heterocyclic amidines, their preparation and use as competitive inhibitors of trypsin-like serine proteases, especially thrombin and kininogenases such as kallikrein. Pharmaceutical compositions which contain the compounds as active ingredients, and use of the compounds as thrombin inhibitors, anticoagulants and antiinflammatory agents.
